Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies

Clinical trial NCT00710528 · COMPLETED

Trial details

NCT number: NCT00710528
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia (CLL)Lymphoma, Non-Hodgkin (NHL)Acute Myeloid Leukemia (AML)Multiple Myeloma (MM)

Start date: 2008-06-01
Primary completion: 2011-12-01
Enrollment: 192

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.